This could be the catalyst needed to break short term resistance between 1.2-1.4 range. Confirmed, ARR just jumped $2.2M per annum on this announcement alone. Massive milestone for the team, commercial launch of DSD & Swiftstatement.
"These achievements are significant commercial milestones for the Company that ensure continued revenue growth of at least $2.2m per annum, that includes $1.5m in the current quarter. Noting that both Capricorn and Spenda are investing heavily in go-to-market activities to deliver success with these critical strategic initiatives, which Spenda anticipates will generate strong maintainable ARR and growth into 2025. These minimum revenues represent a growth of 44% in annual revenue"
What other new revenue streams are planned between Capricorn & Spenda? Appears the real revenue growth that we have all been waiting for starts now.
- Forums
- ASX - By Stock
- SPX
- Ann: Capricorn Initiatives Update
SPX
spenda limited
Add to My Watchlist
9.09%
!
0.6¢

Ann: Capricorn Initiatives Update, page-25
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.6¢ |
Change
0.001(9.09%) |
Mkt cap ! $27.69M |
Open | High | Low | Value | Volume |
0.6¢ | 0.7¢ | 0.6¢ | $23.32K | 3.880M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 280696 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 18216262 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 280696 | 0.006 |
51 | 24939523 | 0.005 |
8 | 15700000 | 0.004 |
9 | 26100000 | 0.003 |
5 | 17000002 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 18124441 | 28 |
0.008 | 4141717 | 24 |
0.009 | 11710538 | 17 |
0.010 | 846836 | 6 |
0.011 | 527004 | 4 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
SPX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online